Nuzenio

Enliven Therapeutics

Enliven Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 15 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 10 Aug 2026 04:04:02 GMTHow (ELVN) Movements Inform Risk Allocation Models - Stock Traders Daily
Sat, 08 Aug 2026 14:31:00 GMTLifeSci Capital Maintains Enliven Therapeutics(ELVN.US) With Buy Rating, Maintains Target Price $70 - Moomoo
Sat, 08 Aug 2026 03:55:41 GMTLifeSci Capital Maintains Enliven Therapeutics(ELVN.US) With Buy Rating, Raises Target Price to $70 - Moomoo
Fri, 07 Aug 2026 02:15:04 GMTEnliven Therapeutics (ELVN) director exercises options, sells 158,795 shares - Stock Titan
Fri, 07 Aug 2026 00:32:10 GMTInsider Sale: Director at $ELVN Sells 158,795 Shares - Moomoo
Thu, 06 Aug 2026 22:49:06 GMTA Quick Look at Today's Ratings for Enliven Therapeutics(ELVN.US), With a Forecast Between $68 to $82 - Moomoo

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Enliven Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.